AOD-9604 acts on adipocyte lipolysis pathways through beta-3 adrenergic receptor signalling, with effects measured at the fat cell level
Summary AOD-9604 is a compact, well-studied growth hormone fragment with a narrow lipolytic mechanism, a strong safety record in toxicology studies, and a clear position in metabolic research as a GH-receptor-independent tool compound
By choosing Mod GRF 1-29 (without DAC), you are selecting a compound that respects physiological feedback loops, offering a highly controlled, pulsatile model for growth hormone research
However, the foundational mechanism paper (Benoist et al., 2014 in J Pharmacol Exp Ther) establishing Dihexas HGF/c-Met pathway activation was formally retracted in April 2025 after being flagged since 2021
Thus, the IL-17 agonist, a promising immunomodulator, represents a valuable candidate for the development of novel antifungal agents (Zhang et al., 2025)
In a different study, the impact of methotrexate was evaluated in a Swiss mouse skin tumor model methylcholanthrene (MCA)